Reference : Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Befor...
Scientific journals : Article
Human health sciences : Gastroenterology & hepatology
http://hdl.handle.net/2268/38481
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
English
Arijs, I. [> > > >]
De Hertogh, G. [> > > >]
Lemaire, K. [> > > >]
Quintens, R. [> > > >]
Van Lommel, L. [> > > >]
Van Steen, Kristel mailto [Université de Liège - ULg > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique >]
Leemans, P. [> > > >]
Cleynen, I. [> > > >]
Van Assche, G. [> > > >]
Vermeire, S. [> > > >]
Geboes, K. [> > > >]
Schuit, F. [> > > >]
Rutgeerts, P. [> > > >]
2009
PLoS ONE
Public Library of Science
4
11
7984
Yes (verified by ORBi)
International
1932-6203
San Franscisco
CA
[en] alpha-defensin expression ; ileal crohns-disease ; ulcerative-colitis ; colon ; mice ; induction ; system ; ileum
[en] Background: Antimicrobial peptides (AMPs) protect the host intestinal mucosa against microorganisms. Abnormal expression of defensins was shown in inflammatory bowel disease (IBD), but it is not clear whether this is a primary defect. We investigated the impact of anti-inflammatory therapy with infliximab on the mucosal gene expression of AMPs in IBD. Methodology/Principal Findings: Mucosal gene expression of 81 AMPs was assessed in 61 IBD patients before and 4-6 weeks after their first infliximab infusion and in 12 control patients, using Affymetrix arrays. Quantitative real-time reverse-transcription PCR and immunohistochemistry were used to confirm microarray data. The dysregulation of many AMPs in colonic IBD in comparison with control colons was widely restored by infliximab therapy, and only DEFB1 expression remained significantly decreased after therapy in the colonic mucosa of IBD responders to infliximab. In ileal Crohn's disease (CD), expression of two neuropeptides with antimicrobial activity, PYY and CHGB, was significantly decreased before therapy compared to control ileums, and ileal PYY expression remained significantly decreased after therapy in CD responders. Expression of the downregulated AMPs before and after treatment (DEFB1 and PYY) correlated with villin 1 expression, a gut epithelial cell marker, indicating that the decrease is a consequence of epithelial damage. Conclusions/Significance: Our study shows that the dysregulation of AMPs in IBD mucosa is the consequence of inflammation, but may be responsible for perpetuation of inflammation due to ineffective clearance of microorganisms.
http://hdl.handle.net/2268/38481

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Arijs_2009_Mucosal Gene.pdfPublisher postprint675.97 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.